NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Genomate Health

Genomate Health

Private
Cambridge, MassachusettsHealthcare & Life Scienceshttps://genomate.health/

Last Round

VC Round

May 5, 2025

Total Funding Raised

$2.25M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Genomate Health is a digital health company that provides a clinically validated, AI-powered computational platform to help oncologists make personalized cancer treatment decisions.

Sector

Healthcare & Life Sciences

Verticals

Precision Medicine, Medical AI, Healthcare Analytics

Business Model

B2B

Customer Profile

Services & Consulting, Subscription SaaS

AI Layer

Application

Keywords

precision medicineclinical decision supportoncology AIgenomic analysismolecular diagnosticsAI oncologycancer treatment matchingpersonalized medicineSaaSclinical decision support systemCDSSmedtechdigital healthhealthcare analyticsAI-driven diagnostics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Genomate Health Comps

Public and private peers based on sector, stage, and business model.

Genomate Health comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Genomate Health Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundMay 5, 2025
VC RoundFeb 11, 2025
SeedApr 16, 2024

Key People

Founding team and executive leadership

Istvan Petak

Founder and Chief Scientific Officer

Founding Team

Nabil Hafez

Chief Executive Officer

Executive Team

Peter Filotas

Chief Technology Officer

Executive Team

Genomate Health Investors

Notable investors and investment history

Genomate Health investors
InvestorRounds
Plug and Play Tech CenterVC Round
Mayo Clinic PlatformSeed
STRT HoldingVC Round
OktogonVC Round
Accessio Equity PartnersVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 14, 2026

    Acquired precision medicine company Oncompass Medicine.

  • Jan 13, 2026

    Technology-enabled, physician-led oncology second-opinion program now available.

Genomate Health Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Genomate Health Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Genomate Health's valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge, Massachusetts
Employee Range31
Year Founded2022
Last FundingMay 5, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.